BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cai WK, Sima H, Chen BD, Yang GS. Risk factors for hilar cholangiocarcinoma: A case-control study in China. World J Gastroenterol 2011; 17(2): 249-253 [PMID: 21246000 DOI: 10.3748/wjg.v17.i2.249]
URL: https://www.wjgnet.com/1007-9327/full/v17/i2/249.htm
Number Citing Articles
1
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 501 doi: 10.1007/978-3-319-26956-6_27
2
Enrico Pinotti, Marta Sandini, Simone Famularo, Nicolò Tamini, Fabrizio Romano, Luca Gianotti. Resection of the caudate lobe for the treatment of hilar cholangiocarcinomaMinerva Chirurgica 2019; 74(4) doi: 10.23736/S0026-4733.18.07498-9
3
Jianping Xiong, Yaqin Wang, Hanchun Huang, Jin Bian, Anqiang Wang, Junyu Long, Ying Zheng, Xinting Sang, Yiyao Xu, Xin Lu, Haitao Zhao. Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinomaOncotarget 2017; 8(35): 59648 doi: 10.18632/oncotarget.19570
4
Dan Huang, Hyundeok Joo, Nan Song, Sooyoung Cho, Woosung Kim, Aesun Shin. Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysisEpidemiology and Health 2021; 43: e2021011 doi: 10.4178/epih.e2021011
5
Jose L. Flores-Guerrero. Pathogens Associated with the Development of Cancer in Humans2024; : 257 doi: 10.1007/978-3-031-62558-9_13
6
Yi-Lin Huang, Kai-Yan Zhang, Yan-Lin Sun, Men-Bao Qian, Zhaojun Wang. The risk of hepatobiliary complications in Clonorchis and Opisthorchis infection: A systematic review and meta-analysisActa Tropica 2024; 260: 107457 doi: 10.1016/j.actatropica.2024.107457
7
Kanlayanee Sawanyawisuth, Nattawat Tantapotinan, Ratthaphol Kraiklang, Anucha Puapairoj, Chaisiri Wongkham, Gregory J. Riggins, Sopit Wongkham. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinomaAnnals of Hepatology 2016; 15(1): 71 doi: 10.5604/16652681.1184223
8
Ban Seok Lee, Eun-Cheol Park, Seung Woo Park, Chung Mo Nam, Jaehoon Roh. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: A case-control study in KoreaWorld Journal of Gastroenterology 2015; 21(2): 502-510 doi: 10.3748/wjg.v21.i2.502
9
Jeffrey S. Chang, Chia-Rung Tsai, Li-Tzong Chen, Fu-Sheng Wang. Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control StudyPLoS ONE 2013; 8(7): e69981 doi: 10.1371/journal.pone.0069981
10
Xiaofen Zhang, Ziyao Yang, Ziyu Shi, Zijia Zhu, Cai Li, Zhicheng Du, Yiding Zhang, Zipeng Wang, Zhenrui Jiao, Xin Tian, Ji Zhang, Wenlong Zhai, Quancheng Kan. Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controlsThe Journal of Steroid Biochemistry and Molecular Biology 2021; 205: 105775 doi: 10.1016/j.jsbmb.2020.105775
11
S. S. Ho, M. T. V. Chan. Hilar Cholangiocarcinoma2013; : 155 doi: 10.1007/978-94-007-6473-6_15
12
Abhijeet Waghray, Anastasia Sobotka, Carlos Romero Marrero, Bassam Estfan, Federico Aucejo, KV Narayanan Menon. Serum albumin predicts survival in patients with hilar cholangiocarcinomaGastroenterology Report 2016; : gow021 doi: 10.1093/gastro/gow021
13
Yuenan Huang, Liuping You, Weimin Xie, Li Ning, Jinghe Lang. Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysisOncotarget 2017; 8(59): 100570 doi: 10.18632/oncotarget.20141
14
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_27-1
15
Cindy Neuzillet, Marie Decraecker, Hélène Larrue, Line C. Ntanda‐Nwandji, Louise Barbier, Sandrine Barge, Arthur Belle, Carine Chagneau, Julien Edeline, Catherine Guettier, Florence Huguet, Jérémie Jacques, Brigitte Le Bail, Sarah Leblanc, Maïté Lewin, David Malka, Maxime Ronot, Véronique Vendrely, Éric Vibert, Christophe Bureau, Marc Bourliere, Nathalie Ganne‐Carrie, Jean‐Frédéric Blanc. Management of intrahepatic and perihilar cholangiocarcinomas: Guidelines of the French Association for the Study of the Liver (AFEF)Liver International 2024; 44(10): 2517 doi: 10.1111/liv.15948
16
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-AnalysisBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
17
Annarosa Floreani, Manola Lisiero, Tatjana Baldovin, Vincenzo Baldo. Epidemiological aspects of biliary tree tumors in a region of northern ItalyEuropean Journal of Gastroenterology & Hepatology 2013; 25(11): 1347 doi: 10.1097/MEG.0b013e3283636cfb
18
Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong. Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta‐analysis and systematic reviewJournal of Gastroenterology and Hepatology 2012; 27(10): 1561 doi: 10.1111/j.1440-1746.2012.07207.x
19
Tingting Shi, Asahiro Morishita, Hideki Kobara, Tsutomu Masaki. The Role of microRNAs in CholangiocarcinomaInternational Journal of Molecular Sciences 2021; 22(14): 7627 doi: 10.3390/ijms22147627
20
Hans Francis Schoellhammer, Yuman Fong, Gagandeep Singh. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 818 doi: 10.1016/B978-0-323-34062-5.00051-0
21
Ban Seok Lee, Byung Hyo Cha, Eun‐Cheol Park, Jaehoon Roh. Risk factors for perihilar cholangiocarcinoma: A hospital‐based case–control studyLiver International 2015; 35(3): 1048 doi: 10.1111/liv.12618
22
Hao Li, Bin Hu, Zun-Qiang Zhou, Jiao Guan, Zheng-Yun Zhang, Guang-Wen Zhou. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studiesWorld Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0583-9
23
Yong Liu, Guangbing Li, Ziwen Lu, Tao Wang, Yang Yang, Xiaoyu Wang, Jun Liu. Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysisPeerJ 2021; 9: e12184 doi: 10.7717/peerj.12184
24
Atsushi Tanaka. Is Hepatitis B Virus–Associated Intrahepatic Cholangiocarcinoma Preventable With Antiviral Treatment?Clinical Gastroenterology and Hepatology 2018; 16(6): 821 doi: 10.1016/j.cgh.2017.12.041
25
Men-Bao Qian, Ying-Dan Chen, Song Liang, Guo-Jing Yang, Xiao-Nong Zhou. The global epidemiology of clonorchiasis and its relation with cholangiocarcinomaInfectious Diseases of Poverty 2012; 1(1) doi: 10.1186/2049-9957-1-4
26
Neha Lad, David A. Kooby. Distal CholangiocarcinomaSurgical Oncology Clinics of North America 2014; 23(2): 265 doi: 10.1016/j.soc.2013.11.001
27
E. S. Makarov, M. I. Nechushkin, I. A. Gladilina, V. A. Vishnevskiy. Epidemiological and biomolecular aspects of portal cholangiocarcinoma (literature review)Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2018; 23(2): 111 doi: 10.16931/1995-5464.20182111-118
28
Jing Xia, Shi-chen Jiang, Hong-Juan Peng, Mark Spigelman. Association between Liver Fluke Infection and Hepatobiliary Pathological Changes: A Systematic Review and Meta-AnalysisPLOS ONE 2015; 10(7): e0132673 doi: 10.1371/journal.pone.0132673